- Home
- SVT vs ELEV Comparison
SVT vs ELEV Comparison
Compare SVT & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- ELEV
- Stock Information
- Founded
- SVT 1959
- ELEV 2019
- Country
- SVT United States
- ELEV United States
- Employees
- SVT N/A
- ELEV N/A
- Industry
- SVT Industrial Machinery/Components
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- SVT Consumer Discretionary
- ELEV Health Care
- Exchange
- SVT Nasdaq
- ELEV Nasdaq
- Market Cap
- SVT 26.8M
- ELEV 22.8M
- IPO Year
- SVT N/A
- ELEV 2021
- Fundamental
- Price
- SVT $47.01
- ELEV $0.39
- Analyst Decision
- SVT
- ELEV Hold
- Analyst Count
- SVT 0
- ELEV 6
- Target Price
- SVT N/A
- ELEV $1.77
- AVG Volume (30 Days)
- SVT 51.9K
- ELEV 2.0M
- Earning Date
- SVT 08-07-2025
- ELEV 08-05-2025
- Dividend Yield
- SVT N/A
- ELEV N/A
- EPS Growth
- SVT N/A
- ELEV N/A
- EPS
- SVT N/A
- ELEV N/A
- Revenue
- SVT $46,174,000.00
- ELEV N/A
- Revenue This Year
- SVT N/A
- ELEV N/A
- Revenue Next Year
- SVT N/A
- ELEV N/A
- P/E Ratio
- SVT N/A
- ELEV N/A
- Revenue Growth
- SVT 2.58
- ELEV N/A
- 52 Week Low
- SVT $9.67
- ELEV $0.22
- 52 Week High
- SVT $47.15
- ELEV $3.28
- Technical
- Relative Strength Index (RSI)
- SVT 95.82
- ELEV 62.35
- Support Level
- SVT $46.86
- ELEV $0.38
- Resistance Level
- SVT $47.15
- ELEV $0.39
- Average True Range (ATR)
- SVT 0.12
- ELEV 0.01
- MACD
- SVT -1.22
- ELEV 0.00
- Stochastic Oscillator
- SVT 68.18
- ELEV 85.00
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users. Geographically, the company generates the majority of its revenue from the Domestic market.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.